 ThirdAge | Abbott Labs says FDA clears leukemia test BusinessWeek The Vysis EGR1 FISH Probe Kit can help physicians determine which patients can be treated with chemotherapy, the first option for AML, and who has more severe disease and may require a stem cell transplant. The test detects a deletion in part of a ... FDA Okays Genetic Test to Peg AML Prognosis Acute Myeloid Leukemia Test Cleared By FDA Abbott's Genetic Test for Acute Myeloid Leukemia Prognosis Cleared by FDA |
